Table 1.

Patient characteristics

Patient No.	Age at diagnosis (years)	Follow-up (months)	FIGO	Pelvic nodes	Para-aortic nodes	Site of first recurrence
1	32	51	IB	Yes, pN1 (1/32)	No	No progression
2	35	66	IB	Yes, pN1 (4/32)	No	No progression
3	30	44	IIA	Yes, pN1 (4/25)	No	Multiple
4	71	12	IIA	Yes, radiologic	No	Local
5	55	84	IIB	No, radiologic	No	No progression
6	61	79	IIB	No, radiologic	No	No progression
7	47	32	IIB	No, pN0 (0/39)	No	Unknown
8	47	63	IIB	No, radiologic	No	No progression
9	33	8	IIB	Yes, pN1 (9/20; ece+)	No	Unknown
10	62	49	IIB	No, radiologic	No	No progression
11	46	73	IIB	Yes, pN1 (1/19)	No	No progression
12	63	30	IIB	No, radiologic	No	Unknown
13	46	8	IIB	Yes, pN1 (17/23)	No	Unknown
14	73	49	IIB	No, radiologic	No	Unknown
15	48	39	IIB	Yes, pN1 (4/32)	No	No progression
16	39	45	IIB	No, radiologic	No	No progression
17	32	50	IIB	No, radiologic	No	No progression
18	44	36	IIB	No, radiologic	No	No progression
19	53	13	IIB	No, pN0 (0/32)	No	No progression
20	57	21	IIB	No, radiologic	No	Local
21	65	49	IIB	No, pN0 (0/31)	No	No progression
22	58	64	IIB	Yes, radiologic	No	No progression
23	77	11	IIIB	No, radiologic	No	Multiple
24	67	66	IIIB	No, radiologic	No	No progression
25	74	35	IIIB	No, radiologic	No	Multiple
26	65	12	IIIB	No, radiologic	No	Liver
27	32	58	IVA	Yes, pN1	Yes, pM1 (LYM)	No progression
28	51	76	IVA	Yes, pN1 (9/40)	Yes, pM1 (LYM)	No progression
29	57	30	IVA	Yes, radiologic	Yes	Lung
30	57	14	IVA	Yes, pN1 (24/35)	Yes, pM1 (20/21) (LYM)	Unknown
31	49	12	IVA	Yes, radiologic	No	Lymph nodes
Mean	52 (30–77)	41 (8–84)	–	–	–	–

LYM lymph node metastasis, ECE+ extracapsular extention